Data / Form D filings / BioSynchronicity Corp
BioSynchronicity Corp: Form D filings
BioSynchronicity Corp, a biotechnology company in Spokane, WA, filed 6 Form D notices with the SEC between 2021 and 2025. The latest, on December 2, 2025, reports an offering of $1 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- REGISTERED AGENTS INC., 100 N. HOWARD ST, STE R, Spokane, WA, 99201
- Phone
- (310) 897-8787
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Washington
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1848527
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Amendment | $1,000,000 | $0 | $1,000,000 | 0 | Yet to occur | sec.gov |
| Jul 22, 2024 | New notice | $1,250,000 | $0 | $1,250,000 | 0 | Yet to occur | sec.gov |
| Jul 31, 2023 | New notice | $800,000 | $10,000 | $790,000 | 1 | Jul 21, 2023 | sec.gov |
| Jun 28, 2023 | New notice | $200,000 | $25,000 | $175,000 | 2 | Jun 23, 2023 | sec.gov |
| Jul 26, 2022 | New notice | $300,000 | $150,000 | $150,000 | 0 | Jul 7, 2022 | sec.gov |
| Mar 2, 2021 | New notice | $300,000 | $130,000 | $170,000 | 5 | Feb 16, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bharat Rao | Director | |
| Robert Katz | Director | |
| Muriel Wood | Executive Officer |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Dec 1, 2025 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BioSynchronicity Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.